Related Experiment Video

Updated: Jun 19, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells

Yoshitaka Sekido1

  • 1Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan. ysekido@aichi-cc.jp

Cancer Science
|October 2, 2009
PubMed

Insights

Malignant mesothelioma (MM) involves genetic changes in tumor suppressor genes like NF2 and epigenetic silencing. Research is uncovering key molecular pathways driving MM cell growth for targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant mesothelioma (MM) is a poor-prognosis cancer linked to asbestos exposure.
  • The precise mechanisms by which asbestos induces cellular transformation remain under investigation.
  • Understanding MM pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the key molecular mechanisms driving the development, proliferation, and invasion of MM cells.
  • To identify critical signaling pathways that MM cells depend on for survival and proliferation.
  • To lay the groundwork for novel molecular targeted therapies for MM.

Main Methods:

  • Analysis of genetic alterations, including tumor suppressor gene inactivation (e.g., NF2, p16INK4a/p14ARF) and epigenetic modifications (e.g., RASSF1A).
  • Investigation of activated signaling pathways, such as receptor tyrosine kinases (EGFR, MET) and downstream cascades (MAPK, PI3K-AKT).
  • Exploration of the tumor-suppressive role of Merlin and its connection to the Hippo pathway.

Main Results:

  • Frequent genetic inactivation of p16INK4a/p14ARF and NF2 (Merlin), and epigenetic inactivation of RASSF1A are characteristic of MM.
  • Unlike other cancers, MM lacks frequent mutations in common oncogenes like K-RAS and PIK3CA.
  • Activation of EGFR family, MET, and downstream MAPK and PI3K-AKT pathways are commonly observed in MM cells.

Conclusions:

  • Dysregulated signaling cascades, particularly those involving receptor tyrosine kinases and their downstream effectors, are critical for MM cell survival and proliferation.
  • Further detailed investigation of these aberrant pathways will identify key addiction mechanisms.
  • This knowledge is essential for the development of new molecularly targeted therapies for malignant mesothelioma.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...